Role of Apomorphine in the Treatment of Parkinson’s Disease

被引:0
|
作者
Allison Boyle
William Ondo
机构
[1] University of Texas Health Science Center at Houston,
来源
CNS Drugs | 2015年 / 29卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Current research shows that apomorphine is an effective treatment for symptoms of Parkinson’s Disease (PD). The highly lipophilic structure allows apomorphine to cross cell membranes rapidly, leading to the rapid onset of action for on/off symptoms of PD. The use of apomorphine was limited in the past due to peripheral side effects, but with the advent of better delivery systems and medications to control side effects, apomorphine is better tolerated and more widely in use. The major delivery systems are continuous subcutaneous infusions and intermittent subcutaneous injections, but other delivery routes are under investigation. The purpose of this article is to discuss the current use of apomorphine, the current delivery systems and to discuss future research.
引用
收藏
页码:83 / 89
页数:6
相关论文
共 50 条
  • [1] The role of apomorphine in the treatment of Parkinson's disease
    Ruzicka, E
    Roth, J
    5TH CONGRESS OF THE EUROPEAN SOCIETY FOR CLINICAL NEUROPHARMACOLOGY, 2000, : 15 - 23
  • [2] Role of Apomorphine in the Treatment of Parkinson's Disease
    Boyle, Allison
    Ondo, William
    CNS DRUGS, 2015, 29 (02) : 83 - 89
  • [3] Apomorphine in the treatment of Parkinson's disease
    Menon, Rukmini
    Stacy, Mark
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (12) : 1941 - 1950
  • [4] Apomorphine in the treatment of Parkinson's disease
    Dressler, D
    NERVENARZT, 2005, 76 (06): : 681 - +
  • [5] Apomorphine in the Treatment of Parkinson's Disease
    Ozkan, Serhat
    Erer, Sevda
    Elibol, Bulent
    Ozkaynak, Sehur Sibel
    Cakmur, Raif
    Akbostanci, Muhittin Cenk
    Hanagasi, Hasmet
    Dogu, Okan
    TURKISH JOURNAL OF NEUROLOGY, 2021, 27 (04) : 358 - 365
  • [6] Apomorphine in the treatment of Parkinson's disease: a review
    Pessoa, Renata Ramina
    Moro, Adriana
    Munhoz, Renato Puppi
    Teive, Helio A. G.
    Lees, Andrew J.
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2018, 76 (12) : 840 - 848
  • [7] Apomorphine hydrochloride for the treatment of Parkinson's disease
    Unti, Elisa
    Ceravolo, Roberto
    Bonuccelli, Ubaldo
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (07) : 723 - 732
  • [8] Sublingual apomorphine in the treatment of Parkinson's disease
    Kassubek, Jan
    Jost, Wolfgang H.
    Schwarz, Johannes
    JOURNAL OF NEURAL TRANSMISSION, 2024, 131 (10) : 1209 - 1216
  • [9] The role of subcutaneous infusion of apomorphine in Parkinson's disease
    Wenzel, Karoline
    Homann, Carl Nikolaus
    Fabbrini, Giovanni
    Colosimo, Carlo
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2014, 14 (07) : 833 - 843
  • [10] An evaluation of subcutaneous apomorphine for the treatment of Parkinson's disease
    Mueller, Thomas
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (14) : 1659 - 1665